Please try another search
| Name | Net % | Long % | Short % |
|---|---|---|---|
| Cash | 3.890 | 3.890 | 0.000 |
| Shares | 96.250 | 96.250 | 0.000 |
| Ratios | Value | Category Average |
|---|---|---|
| P/E Ratio | 24.411 | 19.729 |
| Price to Book | 7.571 | 3.357 |
| Price to Sales | 4.640 | 2.492 |
| Price to Cash Flow | 18.673 | 12.777 |
| Dividend Yield | 1.149 | 1.951 |
| 5 Years Earnings Growth | 9.541 | 9.951 |
| Name | Net % | Category Average |
|---|---|---|
| Technology | 43.490 | 21.892 |
| Healthcare | 36.740 | 12.464 |
| Communication Services | 19.770 | 10.292 |
Number of long holdings: 30
Number of short holdings: 1
| Name | ISIN | Weight % | Last | Change % | |
|---|---|---|---|---|---|
| NVIDIA | US67066G1040 | 9.63 | 186.26 | +2.25% | |
| Microsoft | US5949181045 | 8.49 | 523.61 | +0.59% | |
| Apple | US0378331005 | 7.30 | 262.82 | +1.25% | |
| Alphabet A | US02079K3059 | 7.20 | 259.92 | +2.70% | |
| Meta Platforms | US30303M1027 | 6.43 | 738.36 | +0.59% | |
| Eli Lilly | US5324571083 | 4.90 | 825.45 | +0.54% | |
| Roche Holding Participation | CH0012032048 | 4.71 | 271.20 | -0.15% | |
| Novartis | CH0012005267 | 4.63 | 104.08 | -0.42% | |
| UnitedHealth | US91324P1021 | 4.21 | 362.50 | +0.57% | |
| Broadcom | US11135F1012 | 4.10 | 354.13 | +2.86% |
| Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
|---|---|---|---|---|---|---|
| Renaissance Global Growth CAD | 5.21B | 3.48 | 15.56 | 9.66 | ||
| Renaissance Global Growth Cl F CAD | 5.21B | 4.48 | 17.06 | 11.09 | ||
| Renaissance International Eq CAD | 1.79B | 3.15 | 11.23 | 6.37 | ||
| Renaissance International Eq Cl CAD | 1.79B | 4.14 | 12.66 | 7.79 | ||
| Renaissance US Equity Income F CAD | 1.5B | 5.24 | 11.35 | 9.81 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review